HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Placental 11beta-HSD2 gene expression at birth is inversely correlated with growth velocity in the first year of life after intrauterine growth restriction.

Abstract
Intrauterine growth restriction (IUGR) is associated with an increased risk for short stature and diseases in adulthood thought to be inflicted by fetal programming. We hypothesized that placental endocrine systems involved in perinatal growth might also play a role in postnatal growth after IUGR. In a prospective controlled multicenter study, placental gene expression of IGF-binding protein-1 (IGFBP-1), leptin and 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) were measured in 14 IUGR infants and 15 children born appropriate for gestational age (AGA) proven by serial ultrasound examinations. Postnatally, IUGR infants experienced a significantly higher growth velocity than AGA neonates (at 1 y: p = 0.001). Gene expression of 11beta-HSD2 at birth correlated positively with birth length (r = 0.55, p = 0.04) and inversely with growth velocity in the first year of life (r = -0.69, p = 0.01) in the IUGR, but not in the AGA group. There was no correlation between gene expression of placental IGFBP-1, leptin and birth weight, length and growth velocity during the first year of life. AGA infants showed significantly higher concentrations of cortisone in venous cord blood after birth (p = 0.02) as a surrogate of a higher 11beta-HSD2 activity in the fetoplacental unit. In conclusion, placental 11beta-HSD2 gene expression might predict postnatal growth in IUGR.
AuthorsAnja Tzschoppe, Ellen Struwe, Holger Blessing, Fabian Fahlbusch, Gisela Liebhaber, Helmuth G Dörr, Manfred Rauh, Wolfgang Rascher, Tamme W Goecke, Ralf L Schild, Ekkehard Schleussner, Cerrie Scheler, Axel Hübler, Peter Dahlem, Jörg Dötsch
JournalPediatric research (Pediatr Res) Vol. 65 Issue 6 Pg. 647-53 (Jun 2009) ISSN: 1530-0447 [Electronic] United States
PMID19218882 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • IGFBP1 protein, human
  • Insulin-Like Growth Factor Binding Protein 1
  • Leptin
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2
Topics
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2 (genetics, metabolism)
  • Anthropometry
  • Birth Weight (genetics)
  • Female
  • Fetal Development (genetics)
  • Fetal Growth Retardation (physiopathology)
  • Gestational Age
  • Humans
  • Infant
  • Insulin-Like Growth Factor Binding Protein 1 (genetics, metabolism)
  • Leptin (genetics, metabolism)
  • Male
  • Placenta (enzymology, physiology)
  • Pregnancy
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: